Xiheng Chen

Xiheng Chen

Auto-generated profile, based on publicly available information

Xiheng Chen

Department of Neurosurgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
SGSiming Gui
Siming Gui
XCXiheng Chen
Xiheng Chen
DWDachao Wei
Dachao Wei
DDDingwei Deng
Dingwei Deng
WYWei You
Wei You
YLYouxiang Li
Youxiang Li
Background: Flow diverters have revolutionized the treatment of intracranial aneurysms. However, the delayed complications associated with flow diverter use are unknown. Objective: To evaluate the incidence, severity, clinical outcomes, risk factors, and dynamic changes associated with in-stent stenosis (ISS) after treatment with a Pipeline embolization device (PED). Methods: Patients who underwent PED treatment between 2015 and 2020 were enrolled. The angiographic, clinical, and follow-up data of 459 patients were independently reviewed by four neuroradiologists to identify ISS. Binary logistic regression was conducted to determine ISS risk factors, and an ISS–time curve was established to demonstrate dynamic changes in ISS after PED implantation. Results: Of the 459 treated patients, 69 (15.0%) developed ISS. At follow-up, nine patients (2.0%) with ISS demonstrated reversal, while 18 (3.9%) developed parental artery occlusion. A total of 380 patients (82.8%) achieved complete aneurysm occlusion (O’Kelly–Marotta grade D). Patients with posterior-circulation aneurysm (OR=2.895, 95% CI (1.732 to 4.838; P54 years (OR=0.464, 95% CI 0.274 to 0.785; P=0.006) or with a body mass index of >28 kg/m2 (OR=0.427, 95% CI 0.184 to 0.991; P=0.026) had a lower ISS risk. Intimal hyperplasia initiated by PED placement peaked within 1 year after the procedure, rarely progressed after 12 months, and tended to reverse within 24 months. Conclusions: ISS is a common, benign, and self-limiting complication of PED implantation in the Chinese population.

17 January 2024 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
WYWei You
Wei You
JFJunqiang Feng
Junqiang Feng
JLJing Lu
Jing Lu
TCTing Chen
Ting Chen
XLXinke Liu
Xinke Liu
YJYuhua Jiang
Yuhua Jiang
Background Detecting and segmenting intracranial aneurysms (IAs) from angiographic images is a laborious task. Objective To evaluates a novel deep-learning algorithm, named vessel attention (VA)-Unet, for the efficient detection and segmentation of IAs. Methods This retrospective study was conducted using head CT angiography (CTA) examinations depicting IAs from two hospitals in China between 2010 and 2021. Training included cases with subarachnoid hemorrhage (SAH) and arterial stenosis, common accompanying vascular abnormalities. Testing was performed in cohorts with reference-standard digital subtraction angiography (cohort 1), with SAH (cohort 2), acquired outside the time interval of training data (cohort 3), and an external dataset (cohort 4). The algorithm’s performance was evaluated using sensitivity, recall, false positives per case (FPs/case), and Dice coefficient, with manual segmentation as the reference standard. Results The study included 3190 CTA scans with 4124 IAs. Sensitivity, recall, and FPs/case for detection of IAs were, respectively, 98.58%, 96.17%, and 2.08 in cohort 1; 95.00%, 88.8%, and 3.62 in cohort 2; 96.00%, 93.77%, and 2.60 in cohort 3; and, 96.17%, 94.05%, and 3.60 in external cohort 4. The segmentation accuracy, as measured by the Dice coefficient, was 0.78, 0.71, 0.71, and 0.66 for cohorts 1–4, respectively. VA-Unet detection recall and FPs/case and segmentation accuracy were affected by several clinical factors, including aneurysm size, bifurcation aneurysms, and the presence of arterial stenosis and SAH. Conclusions VA-Unet accurately detected and segmented IAs in head CTA comparably to expert interpretation. The proposed algorithm has significant potential to assist radiologists in efficiently detecting and segmenting IAs from CTA images.

5 April 2024 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
LDLinggen Dong
Linggen Dong
CWChao Wang
Chao Wang
DWDachao Wei
Dachao Wei
QPQichen Peng
Qichen Peng
XWXinzhi Wu
Xinzhi Wu
MLMing Lv
Ming Lv
Background Studies reporting spontaneous delayed migration or shortening (SDMS) after treatment with the Pipeline Embolization Device (PED) are limited. This study aimed to evaluate the incidence of SDMS after PED treatment, propose management strategies, and identify the risk factors contributing to its occurrence. Methods We retrospectively reviewed consecutive patients with an intracranial aneurysm (IA) treated with PEDs at three institutions. SDMS was classified as type I or II based on whether the PED covered the aneurysm neck. Results The total cohort comprised 790 patients. SDMS was identified in 24 (3.04%) patients. Eighteen of the 24 patients had type I SDMS and did not require retreatment, while the remaining six patients had type II SDMS and all received retreatment. Multivariate logistic regression showed that the difference between the proximal and distal parent artery diameters (DPAD) (adjusted OR 2.977; 95% CI 1.054 to 8.405; P=0.039) and device tortuosity index (DTI) (adjusted OR 8.059; 95% CI 2.867 to 23.428; P<0.001) were independent predictors of SDMS after PED treatment, while the difference in length (DL) (adjusted OR 0.841; 95% CI 0.738 to 0.958; P=0.009) and PED plus coiling (adjusted OR 0.288; 95% CI 0.106 to 0.785; P=0.015) were protective factors. Conclusion The incidence of SDMS after PED treatment of IA was 3.04%. For patients with type I SDMS with incomplete aneurysm occlusion we recommend continuous imaging follow-up while, for patients with type II SDMS, we recommend aggressive retreatment. The DPAD and DTI were independent risk predictors of SDMS after PED treatment, while the DL and PED plus coiling were protective factors.

5 September 2025 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
LDLinggen Dong
Linggen Dong
DWDachao Wei
Dachao Wei
ZWZizheng Wang
Zizheng Wang
JWJian Wang
Jian Wang
XCXiheng Chen
Xiheng Chen
MLMing Lv
Ming Lv
Background Endovascular treatment (EVT) of vertebrobasilar dissecting aneurysms (VBDAs) is associated with high morbidity and mortality, significantly influencing patient prognosis. This study aimed to develop and validate a nomogram for predicting 30-day outcomes in patients with unruptured VBDAs undergoing EVT. Methods This retrospective study included 606 patients with unruptured VBDAs who underwent EVT at 10 institutions between January 2015 and April 2025, with 491 in the training cohort and 115 in the validation cohort. Poor outcome was defined as a modified Rankin Scale score ≥3. Predictors were identified via least absolute shrinkage and selection operator analysis and multivariable regression analysis. A nomogram was developed using these predictors. The predictive accuracy and clinical utility of the nomogram were evaluated using area under the curve (AUC), calibration curves, and decision curve analysis (DCA). Results Over a 30-day follow-up, 44 patients (9.0%) in the training cohort and 13 patients (11.3%) in the validation cohort experienced poor outcomes. Multivariate logistic regression identified ischemic stroke history (OR 3.393, P=0.021), aneurysms located in the vertebrobasilar artery (OR 2.552, P=0.009), type IV VBDA (OR 1.762, P=0.013), overlapping devices (OR 2.736, P=0.007), and aneurysm width (OR 1.101, P=0.043) as predictors of 30-day poor outcome. A nomogram incorporating these predictors yielded AUCs of 0.851 (95% CI 0.784 to 0.918) and 0.860 (95% CI 0.722 to 0.999) in the training and validation cohorts, respectively. The calibration curve and DCA analyses validate the nomogram’s clinical utility. Conclusion The nomogram provides an individualized prediction of poor outcomes after EVT, serving as a practical risk assessment tool for patients with unruptured VBDAs.

28 April 2025 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
LDLinggen Dong
Linggen Dong
DWDachao Wei
Dachao Wei
ZWZizheng Wang
Zizheng Wang
QPQichen Peng
Qichen Peng
XCXiheng Chen
Xiheng Chen
MLMing Lv
Ming Lv
Background Delayed intraparenchymal hemorrhage (DIPH) is a severe complication after pipeline embolization device (PED) deployment for intracranial aneurysms (IAs). However, predictive models are lacking. This study aims to develop and validate a new nomogram to predict DIPH risk in IA patients. Methods This retrospective study included 959 IA patients treated with PEDs at three institutions between October 2018 and June 2024. Patients were categorized into a training cohort (n=685) and a validation cohort (n=274). Predictors were identified using the least absolute shrinkage and selection operator and multivariable regression analyses. A nomogram was developed based on these predictors. The area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA) were utilized to assess the predictive accuracy and clinical value of the nomograms. Results The incidence of DIPH was 2.3% in the training cohort. Multivariate logistic regression analysis demonstrated that age (odds ratio [OR] per 10 years, 2.063, P=0.005), maximum diameter (OR, 1.099, P=0.004), adenosine diphosphate-induced maximal platelet aggregation (OR, 0.896, P<0.001), and overlapping devices (OR, 7.226, P=0.007) were independent risk factors for DIPH. A nomogram was developed based on these four predictors. The AUCs of the nomogram in the training and validation cohorts were 0.875 (95% CI, 0.762 to 0.988) and 0.886 (95% CI, 0.757 to 1.000), respectively. The calibration curve and DCA analyses confirmed the utility and clinical applicability of the nomogram. Conclusion A simple to use nomogram for the individualized prediction of DIPH after PED treatment in patients with IAs was constructed, which may facilitate early identification of high-risk patients and the development of advanced treatment strategies.

6 February 2026 in Annals of Medicine
Verified
Journal Article
Open access
LDLinggen Dong
Linggen Dong
DWDachao Wei
Dachao Wei
ZWZizheng Wang
Zizheng Wang
QPQichen Peng
Qichen Peng
XCXiheng Chen
Xiheng Chen
PLPeng Liu
Peng Liu
Intracranial aneurysms (IAs) are the primary cause of non-traumatic subarachnoid hemorrhage with high morbidity and mortality [1]. Flow diverters, such as pipeline embolization devices (PEDs), are ...